Lannett Co., Inc.

NYSE:LCI   3:59:54 PM EDT
4.69
-0.29 (-5.82%)
4:00:00 PM EDT: $4.67 -0.02 (-0.43%)
Products

Lannett Announces FDA Acceptance, As A Priority Original ANDA, Of The Generic Advair Diskus® Filing

Published: 06/01/2021 13:41 GMT
Lannett Co., Inc. (LCI) - Lannett Announces FDA Acceptance, As a Priority Original Anda, of the Generic Advair Diskus® Filing.
Lannett Company Inc - FDA Assigned a Generic Drug User Fee Act of 2017 (gdufa Ii) Goal Date for This Priority Original Anda of January 31, 2022.